About Us
Dr. Kingly Pharmaceuticals, a Proud Sister Concern of Visionhub Optical Technology Private Limited operating across the UAE and East African countries including Kenya, Tanzania, Uganda, Rwanda, and Zambia, Dr. Kingly Pharmaceuticals is committed to revolutionizing healthcare. Dr. Kingly is a pharmaceutical company dedicated to developing innovative, high-quality medicines. With a focus on patient-centric solutions and integrity, we strive to improve healthcare outcomes worldwide. Our commitment to excellence, collaboration, and ethics will guide us in shaping a future where we make a meaningful impact on global healthcare outcomes.
As a sister concern of Visionhub, a multinational company in the optical industry in partnership with renowned Japanese brands Hoya and Pentax, we bring the same dedication to innovation and quality to the pharmaceutical field.
Ensuring Health and Happiness for Whole Family.
Quality You Can Rely On
Empowering Wellness with Every Dose.
The Brand Logo
The logo for Dr. Kingly Pharmaceuticals combines two powerful elements: a lion and a chess king, representing both strategy and strength. The lion symbolizes strength, courage, and leadership. The chess king, the most strategic piece in chess, is subtly placed at the lion's chest, symbolizing wisdom, thoughtful decision-making, and control.
The Brand Promise
The slogan "Prescribe with Pride" is our promise to healthcare professionals. It assures doctors they can trust the quality and efficacy of our medicines, knowing they are making the best choice for their patients. This reflects our commitment to integrity, responsibility, and delivering better patient outcomes, allowing doctors to take pride in the care they provide.
Vision
Mission Statement
- Develop and deliver innovative, high-quality medicines that improve the lives of patients and address the evolving needs of healthcare providers.
- Advance medical knowledge and understanding through research, education, and collaboration.
- Provide access to our medicines and healthcare solutions for people around the world.
- Drive sustainable growth and profitability, while maintaining the highest standards of ethics, quality, and compliance.
- Efficient collaboration with the network of channel partners to ensure the timely distribution of our medicines.
- Building trusted, long-term partnerships with healthcare professionals, patients, and communities to enhance medical knowledge and improve health outcomes.
Initiatives
- Expand Product Portfolio: Develop and launch new drugs, biosimilars, or generics to address unmet medical needs and diversify revenue streams.
- Global Expansion: Enter new markets, establish local subsidiaries, and forge strategic partnerships to increase international presence.
- Digital Transformation: Leverage digital technologies to enhance clinical trials, patient engagement, supply chain management, and data analytics.
- Strategic Acquisitions: Acquire or partner with biotech firms, startups, or other pharma companies to access new technologies, products, or markets.
- Manufacturing Capabilities: Invest in state-of-the-art facilities, adopt advanced manufacturing technologies, and ensure compliance with global regulatory standards.